Shiga, Yasuhiro
Shiga, Akina
Mesci, Pinar
Kwon, HyoJun
Brifault, Coralie
Kim, John H.
Jeziorski, Jacob J.
Nasamran, Chanond
Ohtori, Seiji
Muotri, Alysson R.
Gonias, Steven L.
Campana, Wendy M.
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (UL1TR001442)
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (R01 HL136395)
Article History
Received: 11 June 2019
Accepted: 18 November 2019
First Online: 17 December 2019
Competing interests
: Alysson R. Muotri, PhD, is a co-founder and has equity interest in TISMOO, a company dedicated to genetic analysis focusing on therapeutic applications customized for autism spectrum disorder and other neurological disorders with genetic origins. The terms of this arrangement have been reviewed and approved by the University of California San Diego in accordance with its conflict of interest policies. All other authors declare no potential conflict of interest.